Puma Biotechnology Inc expected to post earnings of 5 cents a share - Earnings Preview

Reuters11-05

<a href="https://laohu8.com/S/PBYI">Puma Biotechnology Inc</a> <pbyi.oq> expected to post earnings of 5 cents a share - Earnings Preview </pbyi.oq>

Puma Biotechnology Inc PBYI.OQ PBYI.O is expected to show a fall in quarterly revenue when it reports results on November 6 for the period ending September 30 2025
The Los Angeles California-based company is expected to report a 36.6% decrease in revenue to $51 million from $80.5 million a year ago, according to the estimate from one analyst, based on LSEG data.The company's guidance on August 7 2025, for the period ended September 30, was for revenue between $48.00 million and $51.00 million.
LSEG's mean analyst estimate for Puma Biotechnology Inc is for earnings of 5 cents per share.
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy," 1 "hold" and 1 "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Puma Biotechnology Inc is $4.00, about 26% below its last closing price of $5.04

This summary was machine generated November 4 at 22:42 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2581379395?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-05 06:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2581379395","market":"us","top_or_hot":-1,"title":"Puma Biotechnology Inc  expected to post earnings of 5 cents a share - Earnings Preview","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title><a href=\"https://laohu8.com/S/PBYI\">Puma Biotechnology Inc</a> <pbyi.oq> expected to post earnings of 5 cents a share - Earnings Preview </pbyi.oq></title></head><body><ul><li><p>Puma Biotechnology Inc <span>PBYI.OQ</span> <span>PBYI.O</span> is expected to  show a fall in quarterly revenue when it reports  results on November 6 for the period ending September 30 2025</p></li><li><p>The Los Angeles California-based  company is expected to report a 36.6% decrease in revenue to $51 million from $80.5 million a year ago, according to the estimate from one analyst, based on LSEG data.The company's guidance on August 7 2025, for the period ended September 30, was for revenue between $48.00 million and $51.00 million.</p></li><li><p>LSEG's mean analyst estimate for Puma Biotechnology Inc is for earnings of 5 cents per share. </p></li><li><p>The current average analyst rating on the shares is \"hold\" and the breakdown of recommendations is no \"strong buy\" or \"buy,\" 1 \"hold\" and 1 \"sell\" or \"strong sell.\"  </p></li><li><p>The mean earnings estimate of analysts was unchanged in the last three months. </p></li><li><p>Wall Street's median 12-month price target for Puma Biotechnology Inc is $4.00, about 26% below its last closing price of $5.04</p></li></ul><p>This summary was machine generated November 4 at 22:42 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Puma Biotechnology Inc  expected to post earnings of 5 cents a share - Earnings Preview</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPuma Biotechnology Inc  expected to post earnings of 5 cents a share - Earnings Preview\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-11-05 06:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title><a href=\"https://laohu8.com/S/PBYI\">Puma Biotechnology Inc</a> <pbyi.oq> expected to post earnings of 5 cents a share - Earnings Preview </pbyi.oq></title></head><body><ul><li><p>Puma Biotechnology Inc <span>PBYI.OQ</span> <span>PBYI.O</span> is expected to  show a fall in quarterly revenue when it reports  results on November 6 for the period ending September 30 2025</p></li><li><p>The Los Angeles California-based  company is expected to report a 36.6% decrease in revenue to $51 million from $80.5 million a year ago, according to the estimate from one analyst, based on LSEG data.The company's guidance on August 7 2025, for the period ended September 30, was for revenue between $48.00 million and $51.00 million.</p></li><li><p>LSEG's mean analyst estimate for Puma Biotechnology Inc is for earnings of 5 cents per share. </p></li><li><p>The current average analyst rating on the shares is \"hold\" and the breakdown of recommendations is no \"strong buy\" or \"buy,\" 1 \"hold\" and 1 \"sell\" or \"strong sell.\"  </p></li><li><p>The mean earnings estimate of analysts was unchanged in the last three months. </p></li><li><p>Wall Street's median 12-month price target for Puma Biotechnology Inc is $4.00, about 26% below its last closing price of $5.04</p></li></ul><p>This summary was machine generated November 4 at 22:42 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251104:nL8N3WG3LU:1","article_id":"2581379395","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2581379395","pubTimestamp":1762296124,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Puma Biotechnology Inc  expected to post earnings of5cents a share - Earnings Preview Puma Biotechnology Inc PBYI.OQ PBYI.O is expected to  show a fall in quarterly revenue when it reports  results on","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","PBYI":"Puma Biotechnology Inc"},"translate_title":"Puma Biotechnology Inc预计每股收益为5美分-收益预览","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PBYI":0.9},"content_text":"Puma Biotechnology Inc  expected to post earnings of 5 cents a share - Earnings Preview Puma Biotechnology Inc PBYI.OQ PBYI.O is expected to  show a fall in quarterly revenue when it reports  results on November 6 for the period ending September 30 2025The Los Angeles California-based  company is expected to report a 36.6% decrease in revenue to $51 million from $80.5 million a year ago, according to the estimate from one analyst, based on LSEG data.The company's guidance on August 7 2025, for the period ended September 30, was for revenue between $48.00 million and $51.00 million.LSEG's mean analyst estimate for Puma Biotechnology Inc is for earnings of 5 cents per share. The current average analyst rating on the shares is \"hold\" and the breakdown of recommendations is no \"strong buy\" or \"buy,\" 1 \"hold\" and 1 \"sell\" or \"strong sell.\"  The mean earnings estimate of analysts was unchanged in the last three months. Wall Street's median 12-month price target for Puma Biotechnology Inc is $4.00, about 26% below its last closing price of $5.04This summary was machine generated November 4 at 22:42 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"preview","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2581379395","isCrawlerRequest":true}